AGM/EGMOct 19, 2026, 04:21 PM
iBio Stockholders Approve Share Increase and Incentive Plan Amendment
AI Summary
iBio, Inc. held its 2026 Annual Meeting of Stockholders where key proposals were approved. Stockholders voted to increase the number of authorized shares of Common Stock from 275,000,000 to 500,000,000. Additionally, an amendment to the iBio, Inc. 2023 Omnibus Incentive Plan was approved, modifying the 'evergreen' provision for future share issuances. The meeting also saw the election of two directors and the ratification of the company's independent auditor.
Key Highlights
- iBio, Inc. stockholders approved an amendment to increase authorized shares from 275M to 500M.
- Stockholders approved an amendment to the 2023 Omnibus Incentive Plan, adjusting share reservation for future grants.
- Two directors, William Clark and Gary Sender, were elected to the Board of Directors for three-year terms.
- Grassi & Co., CPAs, P.C. was ratified as the independent registered public accounting firm for fiscal year ending June 30, 2027.
- Stockholders approved, on an advisory basis, the compensation of named executive officers ('say-on-pay').
Price Impact
More from IBIO